A Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma
Clinical trial NCT03434379 · COMPLETED
Trial details
- NCT number
- NCT03434379
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-15
- Primary completion
- 2020-08-31
- Enrollment
- 558
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.